Infinity Pharmaceuticals 10K 2013 Annual report | INFIQ Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Avg

New words: adenopathy, AF, ALT, anemia, aNHL, annum, antibody, Area, ASPIRA, AST, asymptomatic, bankruptcy, bendamustine, BeneFIX, Beth, Bosulif, bosutinib, CDK, commerce, convenient, crossover, CTCL, David, dedicated, Deerfield, default, deletion, delisting, disbursement, dissolution, DUETTSTM, DUO, DUOTM, DYNAMO, DYNAMOTM, EC, ER, ESPP, faculty, Forum, fostamatinib, freely, genomic, guaranty, guide, hematologist, hemophilia, idelalisib, Incyte, iNHL, insolvency, intermediate, Israel, issuable, IWCLL, lymph, marginal, MCL, mechanistic, methotrexate, moiety, monoclonal, monotherapy, multiplied, neutropenia, nodal, Nonrefundable, ofatumumab, onset, ORR, palbociclib, PDUFA, peripheral, pharmacovigilance, prepayment, PTCL, purpura, quotient, radioimmunotherapy, rapid, rash, rationale, ReFacto, repayment, resale, Rhizen, Richter, Rigel, rituximab, Roth, route, ruxolitinib, shipped, SLL, tenure, thrombocytopenic, TM, tradable, transient, undrawn, unpaid, VWAP, whichever, wind, Workshop, worse, Xyntha, zone

Removed: aggregating, alemtuzumab, ALK, Astex, Bachelor, Barcelona, BioMedical, Campath, chaperone, chaperoned, chondrosarcoma, client, composition, convert, counterpart, Debio, Debiopharm, decreased, detailing, diverse, EGFR, erlotinib, Europe, expanded, expiring, folded, gastrointestinal, gene, Genzyme, Gleevec, Hakko, half, heavily, Howard, hundred, ILEX, imatinib, Indiana, inhibiting, inoperable, interim, introduce, joint, Jr, Kirin, Kyowa, leader, legally, locally, long, metastatic, mutant, nilotinib, noncancelable, notoriously, objective, OSI, paclitaxel, pancreatic, Pedro, PharmaMar, potently, Poulenc, properly, provision, Qualifying, regression, remained, requirement, resistant, reversed, Rhone, Rorer, Santabarbara, selectively, selectivity, solid, spent, suggest, Synta, Tarceva, Tasigna, Taxol, Taxotere, transitioned, Tucker, unbenefitted, vital, vote, weekly, wide, Winselow


Name	Jurisdiction of Organization	Percentage Ownership
Infinity Discovery, Inc.	Delaware	100%
Infinity Security Corporation	Massachusetts	100%

Infinity Pharmaceuticals (INFIQ) 10-K2013 FY Annual report

Content analysis